492TiP A phase I study of synthetic lethal, IDE397 (MAT2A inhibitor) as a monotherapy and in combination with chemotherapy in advanced solid tumors harboring MTAP deletion
Authors:
- M.L. JohnsonMJM.L. Johnson
- J. RodonJRJ. Rodon
- R. AljumailyRAR. Aljumaily
- M. Villalona-CaleroMVM. Villalona-Calero
- E. BorazanciEBE. Borazanci
- M. PishvaianMPM. Pishvaian
- A. TurkATA. Turk
- R.D. CarvajalRCR.D. Carvajal
- C. MantiaCMC. Mantia
- G. GiacconeGGG. Giaccone
- Z. MounirZMZ. Mounir
- A. PatelAPA. Patel
- 13 September 2022
- journal article
- abstracts
- Published by Elsevier in Annals of Oncology
- Vol. 33 (7) , S766-S767